Over the Counter Diet Supplementary Market

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of disease.

Over the Counter Diet Supplementary Market contains market size and forecasts of Over the Counter (OTC) & Diet Supplementary in global, including the following market information:

Global Over the Counter (OTC) & Diet Supplementary Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Over the Counter (OTC) & Diet Supplementary Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Over the Counter (OTC) & Diet Supplementary companies in 2021 (%)

The global Over the Counter (OTC) & Diet Supplementary market was valued at 139850 million in 2021 and is projected to reach US$ 204120 million by 2028, at a CAGR of 5.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Analgesic & Pain Relievers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Over the Counter (OTC) & Diet Supplementary include Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer and Sun Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Over the Counter (OTC) & Diet Supplementary manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Over the Counter (OTC) & Diet Supplementary Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Over the Counter (OTC) & Diet Supplementary Market Segment Percentages, by Type, 2021 (%)

Analgesic & Pain Relievers

Dermatological Products

Cough, Cold and Flu Products

Vitamin Supplements

Mineral Supplements

Ophthalmic Products

Global Over the Counter (OTC) & Diet Supplementary Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Over the Counter (OTC) & Diet Supplementary Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Global Over the Counter (OTC) & Diet Supplementary Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Over the Counter (OTC) & Diet Supplementary Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Over the Counter (OTC) & Diet Supplementary revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Over the Counter (OTC) & Diet Supplementary revenues share in global market, 2021 (%)

Key companies Over the Counter (OTC) & Diet Supplementary sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Over the Counter (OTC) & Diet Supplementary sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bayer AG

Merck KGaA

Novartis

Johnson & Johnson

GlaxoSmithKline

Alkem Laboratories

Teva Pharmaceutical Industries

Pfizer

Sun Pharma

Allergan